126
6
Mischoulon and Rosenbaum, op. cit. at 105.(^7) Levine, J., Barak, Y., Gonzalves, M., et al., “Double-blind Controlled Trial of Inositol Treatment of Depression,”
American Journal of Psychiatry 152:792-794 (1995).
(^8) Nierenberg, A.A., Ostracher, M.J., Calabrese, J.R., et al., « Treatment-resistant Bipolar Depression : A STEP-BD
Equipoise Randomized Effectiveness Trial of Antidepressant Augmentation with Lamotrigine, Inositol or
Respiridone,” American Journal of Psychiatry 163(2):210-216 (2006).
(^9) Benjamin, J., Levine, J., Fux, M., et al., “Double-blind, Placebo-controlled, Crossover Study of Inositol Treatment
for Panic Disorder,” American Journal of Psychiatry 152:792-794(1995).
(^10) Mischoulon and Rosenbaum, op. cit. at 106.
(^11) Levine, J., Mishory, A., Susnosky, S., et al., “Combination of Inositol and Serotonin Reuptake Inhibitors in the
Treatment of Depression,” Biological Psychiatry 45:270-273 (1999).
(^12) Iovieno, N., Dalton E. D., Fava, M. & Mischoulon, D., “Second-tier Natural Antidepressants: Review and Critique,”
Journal of Affective Disorders 130(3):343-57 (2011).
(^13) Mischoulon and Rosenbaum, op. cit. at 112.